{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Disorder&page=117", "query": { "condition": "Disorder", "page": 117 }, "page_size": 10 }, "pagination": { "page": 117, "page_size": 10, "total_count": 145445, "total_pages": 14545, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Disorder&page=118&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Disorder&page=116&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T20:54:35.405Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02371369", "title": "Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pigmented Villonodular Synovitis", "Giant Cell Tumors of the Tendon Sheath", "Tenosynovial Giant Cell Tumor" ], "interventions": [ { "name": "Pexidartinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2015-05-11", "completion_date": "2021-04-30", "has_results": true, "last_update_posted_date": "2022-05-11", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 19, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02371369" }, { "nct_id": "NCT02708069", "title": "e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autistic Disorder" ], "interventions": [ { "name": "e-Unstuck", "type": "OTHER" }, { "name": "Unstuck and On Target", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "3-C Institute for Social Development", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 97, "start_date": "2017-03-01", "completion_date": "2018-02-28", "has_results": false, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 2, "location_summary": "Rockville, Maryland • Durham, North Carolina", "locations": [ { "city": "Rockville", "state": "Maryland" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02708069" }, { "nct_id": "NCT04149769", "title": "Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Home and Community Setting (SC140121 Study 3)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injury" ], "interventions": [ { "name": "Indego Exoskeleton", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-05-01", "completion_date": "2020-12-31", "has_results": false, "last_update_posted_date": "2020-11-09", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 3, "location_summary": "Tampa, Florida • Rochester, Minnesota • Nashville, Tennessee", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04149769" }, { "nct_id": "NCT03340883", "title": "Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "BION-1301", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Chinook Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2017-11-15", "completion_date": "2019-07-09", "has_results": true, "last_update_posted_date": "2021-04-01", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 7, "location_summary": "West Hollywood, California • Atlanta, Georgia • Columbus, Ohio + 4 more", "locations": [ { "city": "West Hollywood", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03340883" }, { "nct_id": "NCT00595283", "title": "Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Parent Child Interaction Therapy-Emotion Development (PCIT-ED)", "type": "BEHAVIORAL" }, { "name": "Developmental Education Parenting Intervention (DEPI)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "3 Years to 6 Years" }, "enrollment_count": 38, "start_date": "2007-10", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2013-03-22", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00595283" }, { "nct_id": "NCT02592941", "title": "Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Deflazacort", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PTC Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2018-02-28", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 42, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02592941" }, { "nct_id": "NCT03037541", "title": "Cryosurgery and Cream Combination for Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "Carac Cream", "type": "DRUG" }, { "name": "Placebo Cetaphil cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 60, "start_date": "2011-01-05", "completion_date": "2013-10-29", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03037541" }, { "nct_id": "NCT02655354", "title": "A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Posttraumatic Stress Disorder", "Depression", "Alcohol-Related Disorders", "Suicidal Ideation", "Substance-Related Disorders", "Mild Cognitive Impairment", "Quality of Life", "Pain", "Wounds and Injury", "Brain Injuries", "Chronic Disease" ], "interventions": [ { "name": "Motivational Interviewing", "type": "BEHAVIORAL" }, { "name": "Cognitive Behavioral Therapy Elements", "type": "BEHAVIORAL" }, { "name": "Care Management", "type": "BEHAVIORAL" }, { "name": "Fluoxetine", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Venlafaxine", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Mirtazapine", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Trazodone", "type": "DRUG" }, { "name": "Prazosin", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 635, "start_date": "2015-10", "completion_date": "2019-11", "has_results": true, "last_update_posted_date": "2021-07-02", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 24, "location_summary": "Scottsdale, Arizona • Beverly Hills, California • Sacramento, California + 20 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02655354" }, { "nct_id": "NCT01170754", "title": "Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colon Cancer" ], "interventions": [ { "name": "PEG-3350 and Gatorade", "type": "DRUG" }, { "name": "Golytely 4 liters", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Temple University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 136, "start_date": "2010-04", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2017-09-13", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01170754" }, { "nct_id": "NCT01728805", "title": "Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cutaneous T-Cell Lymphoma" ], "interventions": [ { "name": "KW-0761", "type": "BIOLOGICAL" }, { "name": "Vorinostat", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Kyowa Kirin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 372, "start_date": "2012-11", "completion_date": "2021-02-17", "has_results": true, "last_update_posted_date": "2024-04-25", "last_synced_at": "2026-11-10T20:54:35.405Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Duarte, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01728805" } ] }